Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2004 Jan;19(1):50–53. doi: 10.1007/BF02872389

Nutriceuticals in health and disease prevention

Simmi Kharb 1,✉, Veena Singh 1
PMCID: PMC3453912  PMID: 23105426

Conclusion

Available evidence suggests that we can not dismiss the potential value of nutriceuticals in disease and inhibition of atherosclerosis. Epidemiologic data suggest that antioxidant supplementation may be associated with a reduced risk of clinical events from atherosclerosis; howere, interventional trials only support a role for vitamin E in this regard. Many studies suggest that a link between fruit and vegetables in diet or the amounts of plasma antioxidant vitamins (ascorbic acid, tocopherols and carotenoids) and risk of death from cancer or coronary heart disease. The usefulness of antioxidant for prevention of cardiovascular disease is yet to be proven. However, studies offer important insights that together with the development of methods to identify individuals most likely to benefit, provide hope to clinicians seeking to use antioxidant vitamins with safety and efficacy for the treatment and prevention of cardiovascular disease. Only continued investigation into the mechanism (s) of action of candidate agents will determine whether they hold promise as a therapeutic intervention and only then, they can be recommended routinely to the patients. Thus, nutriceuticals are becoming more widely accepted as an adjunct to conventional therapies.

Full Text

The Full Text of this article is available as a PDF (322.4 KB).

References

  • 1.Sies H., Stahl W. Vitamin E and C, β-Carotene, and other carotoenoids as antioxidants. Am. J. Clin. Nutr. 1995;62:1315S–21S. doi: 10.1093/ajcn/62.6.1315S. [DOI] [PubMed] [Google Scholar]
  • 2.Rimm E.B., Stampfer M.J. Antioxidants for vascular disease. Med. Clin. North America. 2000;84:239–49. doi: 10.1016/S0025-7125(05)70216-9. [DOI] [PubMed] [Google Scholar]
  • 3.Keaney J.E., Simon D.I., Freedman J.E. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB. J. 1999;13:965–76. doi: 10.1096/fasebj.13.9.965. [DOI] [PubMed] [Google Scholar]
  • 4.Hodis H.N., Mack W.J., LaBree L., et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 1995;273:1849–54. doi: 10.1001/jama.273.23.1849. [DOI] [PubMed] [Google Scholar]
  • 5.Stepens N.G., Parsons A., Schofield P.M., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet. 1996;347:781–6. doi: 10.1016/S0140-6736(96)90866-1. [DOI] [PubMed] [Google Scholar]
  • 6.Kritchevsky S.B., Shimakawa T., Tell G.S., et al. Dietary antioxidants and carotid artery wall thickness: the ARIC study. Circulation. 1995;92:2142–50. doi: 10.1161/01.cir.92.8.2142. [DOI] [PubMed] [Google Scholar]
  • 7.Hoeing B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial functions of conduit arteries in patients with chronic heart failure. Circulation. 1998;97:363–8. doi: 10.1161/01.cir.97.4.363. [DOI] [PubMed] [Google Scholar]
  • 8.Solzbach U., Just H., Jeserich M., Hornig B. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 1997;96:1513–9. doi: 10.1161/01.cir.96.5.1513. [DOI] [PubMed] [Google Scholar]
  • 9.Ting H.H., Creager M.A., Ganz P., et al. Vitamin C improves endothelium-dependent vasodilatation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617–22. doi: 10.1161/01.cir.95.12.2617. [DOI] [PubMed] [Google Scholar]
  • 10.Yokoyama H., Lingle D.M., Crestanello J.A., et al. Coenzyme Q10 protects coronary endothelial function from ischaemia reperfusion injury via an antioxidant effect. Surgery. 1996;120:189–96. doi: 10.1016/S0039-6060(96)80287-X. [DOI] [PubMed] [Google Scholar]
  • 11.Stahl W., Sies H. Lycopene: a biologically important corotenoid for humans? Arch. Biochem. Biophys. 1996;336:1–9. doi: 10.1006/abbi.1996.0525. [DOI] [PubMed] [Google Scholar]
  • 12.Agarwal S., Rao A.V. Tomato lycopene and low density topoprotein oxidation: a human dietary intervention study. Lipids. 1998;33:981–4. doi: 10.1007/s11745-998-0295-6. [DOI] [PubMed] [Google Scholar]
  • 13.Kohlmeir L., Kark J.D., Gomez-Garcia E., et al. Lyropene and myocardial infarction risk in the EURAMIC Study. Am. J. Epidemiol. 1997;146:618–26. doi: 10.1093/oxfordjournals.aje.a009327. [DOI] [PubMed] [Google Scholar]
  • 14.Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willet W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 1993;328:1444–9. doi: 10.1056/NEJM199305203282003. [DOI] [PubMed] [Google Scholar]
  • 15.Albanes D., Heinohen O.P., Taylor P.R., et al. Alpha-tocopherol, Betacarotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 1996;88:1560–70. doi: 10.1093/jnci/88.21.1560. [DOI] [PubMed] [Google Scholar]
  • 16.Omenn G.S., Goodman G.E., Thornquist M.D., et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retionol Efficacy Trial. J. Natl. Cancer Inst. 1996;88:1550–9. doi: 10.1093/jnci/88.21.1550. [DOI] [PubMed] [Google Scholar]
  • 17.Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 1995;33:1061–80. doi: 10.1016/0278-6915(95)00077-1. [DOI] [PubMed] [Google Scholar]
  • 18.Hollman P.C.H., Katan M.B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 1997;51:305–10. doi: 10.1016/S0753-3322(97)88045-6. [DOI] [PubMed] [Google Scholar]
  • 19.Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet. 1993;342:1007–11. doi: 10.1016/0140-6736(93)92876-U. [DOI] [PubMed] [Google Scholar]
  • 20.Potter S.M. Soy protein and serum lipids. Curr. Opin. Lipidol. 1996;7:260–4. doi: 10.1097/00041433-199608000-00013. [DOI] [PubMed] [Google Scholar]
  • 21.Laplaud P.M., Lel Ubre A., Chapman M.J. Antioxidant actions of vaccinium myrtillus extract on human low density lipoproteins in vitro: Initial observations. Fundam. Clin. Pharmacol. 1997;11:35–40. doi: 10.1111/j.1472-8206.1997.tb00166.x. [DOI] [PubMed] [Google Scholar]
  • 22.Stromer F.C., Reistad R., Alexander J. Glycyrrhizic acid in liquorice: evaluation of health hazard. Food Chem. Toxicol. 1993;31:303–12. doi: 10.1016/0278-6915(93)90080-I. [DOI] [PubMed] [Google Scholar]
  • 23.Cooke J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Ann. Rev. Med. 1997;48:489–509. doi: 10.1146/annurev.med.48.1.489. [DOI] [PubMed] [Google Scholar]
  • 24.Cooke J.P., Tasao P.A. Arginine: a new therapy for atherosclerosis? Circulation. 1997;95:311–2. doi: 10.1161/01.cir.95.2.311. [DOI] [PubMed] [Google Scholar]
  • 25.Cooke J.P., Tsao P.S. Endothelial alterations in atherosclerosis: the role of nitric oxide. In: Webb D, Vallance P, editors. Endothelial Functions in Hypertension. Heidelberg: Springer India; 1997. pp. 29–38. [Google Scholar]
  • 26.Lerman A., Burnett J.C., Higeno S.T., McKinley L.J., Holmes D.R. Long term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:2123–8. doi: 10.1161/01.cir.97.21.2123. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES